Bertis

BERTIS Inc. has developed an AI-based diagnostic platform aimed at diagnosing cancer and heart diseases. The company's platform utilizes proteomics-based molecular diagnostic technology to discover biomarkers associated with cancer, enabling medical professionals to detect diseases at an early stage and treat them effectively.